{
  "resourceType" : "Bundle",
  "type" : "transaction",
  "entry" : [{
    "resource" : {
      "resourceType" : "MedicinalProductDefinition",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition",
      "extension" : [{
        "url" : "http://ema.europa.eu/fhir/extension/authorisedDoseForm",
        "valueCoding" : {
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }
      }],
      "identifier" : [{
        "system" : "http://ema.europa.eu/fhir/mpId",
        "value" : "SE-100000627-00052196"
      },
      {
        "system" : "http://ema.europa.eu/fhir/eurdId",
        "value" : "1725"
      }],
      "domain" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000000004",
          "code" : "100000000012",
          "display" : "Human use"
        }]
      },
      "status" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000005003",
          "code" : "200000005004",
          "display" : "Current"
        }]
      },
      "indication" : "Imatinib Krka d.d. är indicerat för behandling av: - vuxna och barn med nydiagnostiserad Philadelphiakromosom- (bcr-abl)-positiv (Ph+) kronisk  myeloisk leukemi (KML), för vilka benmärgstransplantation inte är en förstahandsbehandling. - vuxna och barn med (Ph+)-KML i kronisk fas efter terapisvikt med interferon alfa-behandling,  eller i accelererad fas eller blastkris. - vuxna och barn med nyligen diagnosticerad Philadelphia-kromosom-positiv akut lymfoblastisk  leukemi (Ph+ ALL) tillsammans med kemoterapi. - vuxna patienter med recidiverande eller refraktär Ph+ ALL som monoterapi. - vuxna patienter med myelodysplastiska/myeloproliferativa sjukdomar (MDS/MPD) förenat med  rearrangemang av platelet-derived growth factor receptor (PDGFR)-genen. - vuxna patienter med avancerat hypereosinofilt syndrom (HES) och/eller kronisk eosinofil  leukemi (CEL) med FIP1L1-PDGFRα-rearrangemang. Effekten av Imatinib Krka d.d. på utfallet av benmärgstransplantation har inte undersökts. 2 Imatinib Krka d.d. är indicerat för: - behandling av vuxna patienter med Kit (CD 117)-positiva, icke-resecerbara och/eller  metastaserande, maligna gastrointestinala stromacellstumörer (GIST). - adjuvant behandling av vuxna patienter som löper en signifikant risk för recidiv efter resektion  av Kit (CD117)-positiv GIST. Patienter som löper låg eller mycket låg risk för återfall ska inte  få adjuvant behandling. - behandling av vuxna patienter med icke-resecerbara dermatofibrosarkoma protuberans (DFSP)  och vuxna patienter med återkommande och/eller metastaserande DFSP som är olämpliga att  operera. Hos vuxna och barn baseras effekten av imatinib på det sammantagna hematologiska och  cytogenetiska svaret och progressionsfri överlevnad vid KML, på hematologiskt och cytogenetiskt  respons vid Ph+ ALL, MDS/MPD, på hematologisk respons vid HES/CEL och på objektiv  tumörrespons hos vuxna patienter vid icke-resecerbara och/eller metastaserande GIST och DFSP och  på återfallsfri överlevnad vid adjuvant GIST. Erfarenheten av imatinib hos patienter med MDS/MPD  förenat med rearrangemang PDGFR-genen är mycket begränsat (se avsnitt 5.1). Förutom vid nyligen  diagnosticerad KML i kronisk fas finns det inga kontrollerade studier som visar på en klinisk nytta  eller ökad överlevnad för dessa sjukdomar.",
      "legalStatusOfSupply" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072051",
          "code" : "100000072084",
          "display" : "Medicinal product subject to medical prescription"
        }]
      },
      "classification" : [{
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000116677",
          "code" : "100000093533",
          "display" : "L01EA01"
        }]
      }],
      "name" : [{
        "productName" : "Imatinib Krka d.d 400 mg Filmdragerad tablett"
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "MedicinalProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "RegulatedAuthorization",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-RegulatedAuthorization",
      "identifier" : [{
        "system" : "http://ema.europa.eu/fhir/MarketingAuthorizationNumber",
        "value" : "52196"
      }],
      "subject" : [{
        "reference" : "MedicinalProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "type" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/220000000060",
          "code" : "220000000061",
          "display" : "Marketing Authorisation"
        }]
      },
      "region" : [{
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000000002",
          "code" : "100000000535",
          "display" : "Sweden"
        }]
      }],
      "status" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072049",
          "code" : "100000072099",
          "display" : "Valid"
        }]
      },
      "statusDate" : "2016-06-22",
      "holder" : {
        "identifier" : {
          "system" : "https://spor.ema.europa.eu/v1/locations",
          "value" : "LOC-100009540"
        },
        "display" : "KRKA, tovarna zdravil d.d. Novo mesto"
      },
      "case" : {
        "type" : {
          "coding" : [{
            "system" : "http://ema.europa.eu/fhir/authorisationDateType",
            "code" : "dateOfFirstAuthorisation",
            "display" : "First Authorisation"
          }]
        },
        "dateDateTime" : "2016-06-22"
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "RegulatedAuthorization/IMAkrkadd-400mg-Tablet-SE-IS-RegulatedAuthorization"
    }
  },
  {
    "resource" : {
      "resourceType" : "AdministrableProductDefinition",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-AdministrableProductDefinition",
      "status" : "active",
      "formOf" : [{
        "reference" : "MedicinalProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "administrableDoseForm" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }]
      },
      "producedFrom" : [{
        "reference" : "ManufacturedItemDefinition/IMAkrkadd-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
      }],
      "routeOfAdministration" : [{
        "code" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000073345",
            "code" : "100000073619",
            "display" : "Oral use"
          }]
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "AdministrableProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-AdministrableProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "PackagedProductDefinition",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-PackagedProductDefinition",
      "extension" : [{
        "url" : "http://ema.europa.eu/fhir/extension/containedItemQuantity",
        "valueQuantity" : {
          "value" : 10,
          "unit" : "Tablet",
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
          "code" : "200000002152"
        }
      }],
      "packageFor" : [{
        "reference" : "MedicinalProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "description" : "Blister, 30 tabletter",
      "_description" : {
        "extension" : [{
          "url" : "http://ema.europa.eu/fhir/extension/language",
          "valueCoding" : {
            "system" : "http://spor.ema.europa.eu/v1/lists/100000072057",
            "code" : "100000072288",
            "display" : "Swedish"
          }
        }]
      },
      "marketingStatus" : [{
        "country" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000000002",
            "code" : "100000000535",
            "display" : "Sweden"
          }]
        },
        "status" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000072052",
            "code" : "100000072083",
            "display" : "Marketed"
          }]
        },
        "dateRange" : {
          
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "PackagedProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-PackagedProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "ManufacturedItemDefinition",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-ManufacturedItemDefinition",
      "status" : "active",
      "manufacturedDoseForm" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }]
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
          "code" : "200000002152",
          "display" : "Tablet"
        }]
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "ManufacturedItemDefinition/IMAkrkadd-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "IMAkrkadd-400mg-Tablet-SE-IS-Ingredient",
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      },
      {
        "reference" : "ManufacturedItemDefinition/IMAkrkadd-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
      },
      {
        "reference" : "AdministrableProductDefinition/IMAkrkadd-400mg-Tablet-SE-IS-AdministrableProductDefinition"
      }],
      "role" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072050",
          "code" : "100000072072",
          "display" : "Active"
        }]
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "http://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
              "code" : "100000091825",
              "display" : "Imatinib mesilate"
            }]
          }
        },
        "strength" : [{
          "presentationRatio" : {
            "numerator" : {
              "value" : 478,
              "_comparator" : {
                "extension" : [{
                  "url" : "http://ema.europa.eu/fhir/extension/comparator",
                  "valueCoding" : {
                    "system" : "https://spor.ema.europa.eu/v1/lists/100000000008",
                    "code" : "100000000049",
                    "display" : "equal to"
                  }
                }]
              },
              "unit" : "milligram(s)",
              "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
              "code" : "100000110655"
            },
            "denominator" : {
              "value" : 1,
              "unit" : "unit(s)",
              "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
              "code" : "100000110756"
            }
          },
          "referenceStrength" : [{
            "substance" : {
              "concept" : {
                "coding" : [{
                  "system" : "https://spor.ema.europa.eu/v2/SubstanceDefinition",
                  "code" : "100000091894",
                  "display" : "Imatinib"
                }]
              }
            },
            "strengthRatio" : {
              "numerator" : {
                "value" : 400,
                "_comparator" : {
                  "extension" : [{
                    "url" : "http://ema.europa.eu/fhir/extension/comparator",
                    "valueCoding" : {
                      "system" : "https://spor.ema.europa.eu/v1/lists/100000000008",
                      "code" : "100000000049",
                      "display" : "equal to"
                    }
                  }]
                },
                "unit" : "milligram(s)",
                "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
                "code" : "100000110655"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "unit(s)",
                "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
                "code" : "100000110756"
              }
            }
          }]
        }]
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "Ingredient/IMAkrkadd-400mg-Tablet-SE-IS-Ingredient"
    }
  }]
}